Riociguat

Generic Name
Riociguat
Brand Names
Adempas
Drug Type
Small Molecule
Chemical Formula
C20H19FN8O2
CAS Number
625115-55-1
Unique Ingredient Identifier
RU3FE2Y4XI
Background

Riociguat is a soluble guanylate cyclase (sGC) agonist approved in the USA, Europe and several other regions for patients with group I PAH (pulmonary arterial hypertension) in WHO FC II or III; and for the treatment of patients with inoperable CTEPH (chronic thromboembolic pulmonary hypertension), or persistent/recurrent PH (pulmonary hypertension) after pul...

Indication

Riociguat is indicated for the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), (WHO Group 4) after surgical treatment, or inoperable CTEPH, to improve exercise capacity and WHO functional class.
...

Associated Conditions
Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Pulmonary Arterial Hypertension (PAH)
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath